As H1 2026 closes, a single theme dominates the global business landscape: AI is no longer being judged on its promise — it is being judged on its performance. Markets, regulators, and capital allocators are all asking the same question at once.

The most valuable asset in your emotional portfolio: a dream, a big hope, or one of those private little ambitions you keep locked in your secret emotional vault, may try to make a break for it this morning. Before you chase it down the street...

China has approved the NEO brain chip for mass production and patient use, marking a major milestone in brain-computer interface technology. The device helps paralyzed patients control digital devices with their thoughts and reaches commercialization ahead of Neuralink.

When a Vancouver small business gets busy, hiring feels like the obvious answer. Sometimes the real capacity problem is repeatable work that software can handle first.

The second half of 2026 opens with a structural question that did not exist a month ago: who decides when the most capable AI models reach the public, the company that built them or the government reviewing them first.

Today arrives with big-hearted energy and a little extra spotlight, so do not act surprised if the universe hands you a microphone and expects some wise remarks. Jupiter and Leo are bringing creativity, generosity....

A Harvard Medical School study found advanced AI systems outperformed doctors in emergency room diagnoses under controlled testing. Researchers say AI could become a powerful decision-support tool, improving diagnostic accuracy while complementing, not replacing human clinicians.

Charitable giving in Canada was once seen as a simple act of goodwill, such as personal, values-driven, and largely separate from financial planning. Today, the charitable tax credit system has transformed philanthropy into a strategic tool.